Matsuda Masaru 4
4 · Arcutis Biotherapeutics, Inc. · Filed Sep 8, 2025
Insider Transaction Report
Form 4
Matsuda Masaru
See Remarks
Transactions
- Sale
Common Stock
2025-09-04$16.16/sh−36,130$583,716→ 161,234 total
Footnotes (2)
- [F1]The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on June 5, 2025, by the Reporting Person, with a plan end date of September 4, 2026.
- [F2]The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $15.93 to $16.3787, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.